3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Melanoma
44
Carcinoma, Non-Small-Cell Lung
16
Colorectal Neoplasms
14
Lung Neoplasms
11
Neoplasm Metastasis
10
Pancreatic Neoplasms
9
Brain Neoplasms
9
Neoplasms
8
Triple Negative Breast Neoplasms
6
Skin Neoplasms
5
Colonic Neoplasms
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Uveal Melanoma
3
Thyroid Neoplasms
3
Multiple Myeloma
3
Hematologic Neoplasms
3
Glioma
3
Gastrointestinal Stromal Tumors
3
Breast Neoplasms
3
Biliary Tract Neoplasms
3
Solid Tumor
2
Skin Diseases
2
Recurrence
2
Neurofibromatosis 1
2
Lymphoma
2
Leukemia, Hairy Cell
2
Hereditary Sensory and Autonomic Neuropathies
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Interventions
tovorafenib
1
binimetinib
1
Carboplatin
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Noonan Syndrome 5
×
binimetinib
×
Clear all
NCT01885195
2021-02-21
SIGNATURE
Pfizer
Phase 2
Completed
110 enrolled
18 charts